Thrombolytic therapy for venous thromboembolism: Current clinical practice

Journal of Hospital Medicine

Volumn 4, Issue 5, 2009, Pages 313-316

  Stashenko, Gregg J ^a   Hargett, Charles W ^a   Tapson, Victor F ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Pulmonary embolism; Questionnaires; Thromboembolism; Thrombolytic therapy; Venous thrombosis

Indexed keywords

FIBRINOLYTIC AGENT;

ADULT; ARTICLE; CLINICAL PRACTICE; DEEP VEIN THROMBOSIS; DRUG CONTRAINDICATION; DRUG USE; EVALUATION RESEARCH; FIBRINOLYTIC THERAPY; HEART RIGHT VENTRICLE FAILURE; HUMAN; HYPOTENSION; HYPOXEMIA; LUNG EMBOLISM; MEDICAL DECISION MAKING; MEDICAL SPECIALIST; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; PULMONOLOGIST; QUESTIONNAIRE; SYSTEMIC THERAPY; VENOUS THROMBOEMBOLISM;

ADULT; HUMANS; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES; SOUTHEASTERN UNITED STATES; THROMBOLYTIC THERAPY; VENOUS THROMBOEMBOLISM;

EID: 67649843971     PISSN: 15535592     EISSN: 15535606     Source Type: Journal    
DOI: 10.1002/jhm.421     Document Type: Article

References (15)

1. Witty LA, Krichman A, Tapson VF. Thrombolytic therapy for venous thromboembolism. Utilization by practicing pulmonologists. Arch Intern Med. 1994;154:1601-1604.
2. Meneveau N, Schiele F, Vuillemenot A, et al. Streptokinase vs alteplase in massive pulmonary embolism. A randomized trial assessing right heart haemodynamics and pulmonary vascular obstruction. Eur Heart J. 1997; 18:1141-1148.
3. Meneveau N, Schiele F, Metx D, et al. Comparative efficacy of a two-hour regimen of streptokinase versus alteplase in acute massive pulmonary embolism: immediate clinical and hemodynamic outcome and one-year follow-up. J Am Coll Cardiol. 1998;31:1057-1063.
4. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet. 1999;353:1386-1389.
5. Torbicki A, van Beek EJR, Charbonnier B, et al. Guidelines on diagnosis and management of acute pulmonary embolism. Task Force on Pulmonary Embolism, European Society of Cardiology. Eur Heart J. 2000;21: 1301-1336.
6. Sharma GV, Folland ED, McIntyre KM, Sasahara AA. Long-term benefit of thrombolytic therapy in patients with pulmonary embolism. Vasc Med. 2000;5:91-95.
7. Thabut G, Thabut D, Myers RP, et al. Thrombolytic therapy of pulmonary embolism: a meta-analysis. J Am Coll Cardiol. 2002;40:1660-1667.
8. Konstantinides S, Geibel A, Heusel G, et al. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med. 2002; 347:1143-1150.
9. Agnelli G, Becattini C, Kirschstein T. Thrombolysis vs heparin in the treatment of pulmonary embolism: a clinical outcome-based meta-analysis. Arch Intern Med. 2002;162:2537-2541.
10. Campbell A, Fennerty A, Miller AC, et al. British Thoracic Society guidelines for the management of suspected acute pulmonary embolism. Thorax. 2003;58:470-483.
11. Watson LI, Armon MP. Thrombolysis for acute deep vein thrombosis. Cochrane Database Syst Rev. 2004; CD002783.
12. Buller HR, Agnelli G, Hull R, et al. Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126:401S-428S.
13. Wan S, Quinlan DJ, Agnelli G, et al. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials. Circulation. 2004;110:744-749.
14. Dong B, Jirong Y, Liu G, et al. Thrombolytic therapy for pulmonary embolism. Cochrane Database Syst Rev. 2006; CD004437.
15. Dalen JE, Alpert JS, Hirsh J.Thrombolytic therapy for pulmonary embolism: is it effective? Is it safe? When is it indicated? Arch Intern Med. 1997;157:2550-2556.